Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
BARCLAYS PLC (BCS)
NYSEFinancialsBanks - DiversifiedSnapshot 2026-11-04
$22.82-3.71%
Close 2026-11-05 · 1-day change
NYSEFinancialsBanks - DiversifiedSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
3.45 → 3.38 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for BCS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Market share and partnerships | The company is gaining market share and forming partnerships that support growth. | Intact | Loss of key partnerships or market share declines | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a Financials sector exposure, but the evidence is too thin to classify it confidently as a durable compounder, turnaround, or another specific type. The thesis state is unclear because there is not enough recent financial-performance history.
The valuation model has high confidence, but the snapshot gives no valuation level or peer comparison, so whether BCS looks cheap, fair, or expensive cannot be assessed. No fragility signals were triggered, which suggests no identified concentration of expectations risk in this evidence.
Near term, the reported miss risk is low, though the snapshot also notes a run of earnings misses among the company and its industry peers. The broader sector backdrop is neutral, and the evidence does not establish a company-specific fundamental trajectory over the next one to three years.
A key swing factor is interest rates: the snapshot says Financials usually fare better when rates stay high, so rate cuts from the current level could weigh on the sector. Another is earnings and guidance from JPM, BAC, and HSBC, whose results could support or weaken sector momentum.
The one-to-three-year thesis remains uncertain because company-specific financial evidence and valuation comparisons are missing. Sector rates and bellwether results are the clearest factors to watch. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| It expects about $31 billion in revenue this year and $3.4 in earnings per share next year. |
| Under Pressure |
| EPS falls below $3.4 in FY27 |
Diluted EPS: GBP 0.48 per share FY2026-Q3; GAAP. Published target: >= $3.4. Annual target cannot be compared with a quarterly or TTM observation. Oct 22, 20260.48 GBP/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Barclays' total revenue | A primary condition in BARCLAYS PLC's published investment case. The stated target is >= $31 billion. | Under Pressure | revenue falls below $31 billion in FY26 | Revenue: GBP 7.359B FY2026-Q3; GAAP. Published target: >= $31 billion. Annual target cannot be compared with a quarterly or TTM observation. Oct 22, 20267,358,593,000 GBP · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$3.40 → $3.38 · observed estimates
$32.65B → $33.28B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $3.40 | $32,653,005,340 | 2 / 16 |
| 2026-07-25 | $3.40 | $32,653,005,340 | 2 / 16 |
| 2026-07-26 | $3.40 | $32,653,005,340 | 2 / 16 |
| 2026-07-27 | $3.40 | $32,653,005,340 | 2 / 16 |
| 2026-07-28 | $3.40 | $32,653,005,340 | 2 / 16 |
| 2026-07-29 | $3.40 | $32,653,005,340 | 2 / 16 |
| 2026-07-30 | $3.40 | $32,653,005,340 | 2 / 16 |
| 2026-07-31 | $3.43 | $32,897,991,700 | 2 / 16 |
| 2026-08-01 | $3.43 | $32,897,991,700 | 2 / 16 |
| 2026-08-02 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-03 | $3.40 | $32,897,991,700 | 2 / 16 |
| 2026-08-04 | $3.40 | $32,897,991,700 | 2 / 16 |
| 2026-08-05 | $3.40 | $32,919,231,379 | 2 / 16 |
| 2026-08-06 | $3.40 | $32,919,231,379 | 2 / 16 |
| 2026-08-07 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-08 | $3.40 | $32,919,231,379 | 2 / 16 |
| 2026-08-09 | $3.40 | $32,919,231,379 | 2 / 16 |
| 2026-08-10 | $3.40 | $32,919,231,379 | 2 / 16 |
| 2026-08-11 | $3.40 | $32,919,231,379 | 2 / 16 |
| 2026-08-12 | $3.40 | $32,919,231,379 | 2 / 16 |
| 2026-08-13 | $3.40 | $32,919,231,379 | 2 / 16 |
| 2026-08-14 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-15 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-16 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-17 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-18 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-19 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-20 | $3.45 | $43,783,770,685 | 3 / 9 |
| 2026-08-21 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-22 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-23 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-24 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-25 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-26 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-27 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-28 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-29 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-30 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-08-31 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-09-01 | $3.46 | $43,903,509,636 | 3 / 9 |
| 2026-09-02 | $3.45 | $43,903,509,636 | 3 / 9 |
| 2026-09-03 | $3.45 | $43,903,509,636 | 3 / 9 |
| 2026-09-04 | $3.45 | $44,009,954,356 | 3 / 9 |
| 2026-09-05 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-06 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-07 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-08 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-09 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-10 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-11 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-12 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-13 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-14 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-15 | $3.45 | $44,009,954,356 | 2 / 9 |
| 2026-09-16 | $3.45 | $44,107,746,481 | 2 / 9 |
| 2026-09-17 | $3.45 | $44,111,044,860 | 2 / 9 |
| 2026-09-18 | $3.45 | $44,111,044,860 | 2 / 9 |
| 2026-09-19 | $3.45 | $44,111,044,860 | 2 / 9 |
| 2026-09-20 | $3.45 | $44,111,044,860 | 2 / 9 |
| 2026-09-21 | $3.45 | $44,111,044,860 | 2 / 9 |
| 2026-09-22 | $3.45 | $44,111,044,860 | 2 / 9 |
| 2026-09-23 | $3.45 | $44,111,044,860 | 2 / 9 |
| 2026-09-24 | $3.45 | $44,125,829,452 | 2 / 9 |
| 2026-09-25 | $3.45 | $44,125,829,452 | 2 / 9 |
| 2026-09-26 | $3.45 | $44,125,829,452 | 2 / 9 |
| 2026-09-27 | $3.45 | $44,125,829,452 | 2 / 9 |
| 2026-09-28 | $3.45 | $44,125,829,452 | 2 / 9 |
| 2026-09-29 | $3.46 | $44,167,243,936 | 2 / 9 |
| 2026-09-30 | $3.46 | $44,168,310,805 | 2 / 9 |
| 2026-10-01 | $3.46 | $44,168,310,805 | 2 / 9 |
| 2026-10-02 | $3.46 | $44,124,056,280 | 2 / 9 |
| 2026-10-03 | $3.45 | $44,019,661,317 | 2 / 9 |
| 2026-10-04 | $3.45 | $44,019,661,317 | 2 / 9 |
| 2026-10-05 | $3.45 | $44,019,661,317 | 2 / 9 |
| 2026-10-06 | $3.45 | $44,019,661,317 | 2 / 9 |
| 2026-10-07 | $3.44 | $43,966,644,079 | 2 / 9 |
| 2026-10-08 | $3.44 | $43,966,644,079 | 2 / 9 |
| 2026-10-09 | $3.44 | $43,966,644,079 | 2 / 9 |
| 2026-10-10 | $3.44 | $43,836,837,258 | 2 / 9 |
| 2026-10-11 | $3.44 | $43,836,837,258 | 2 / 9 |
| 2026-10-12 | $3.44 | $43,836,837,258 | 2 / 9 |
| 2026-10-13 | $3.43 | $43,798,540,779 | 2 / 9 |
| 2026-10-14 | $3.42 | $43,738,521,301 | 2 / 9 |
| 2026-10-15 | $3.41 | $43,730,957,652 | 2 / 9 |
| 2026-10-16 | $3.40 | $43,605,282,965 | 2 / 9 |
| 2026-10-17 | $3.40 | $43,605,282,965 | 2 / 9 |
| 2026-10-18 | $3.40 | $43,605,282,965 | 2 / 9 |
| 2026-10-19 | $3.40 | $43,605,282,965 | 2 / 9 |
| 2026-10-20 | $3.41 | $43,605,282,965 | 2 / 9 |
| 2026-10-21 | $3.41 | $43,605,282,965 | 2 / 9 |
| 2026-10-22 | $3.41 | $43,596,728,104 | 2 / 9 |
| 2026-10-23 | $3.40 | $43,747,915,265 | 2 / 9 |
| 2026-10-24 | $3.39 | $43,895,527,350 | 2 / 9 |
| 2026-10-25 | $3.39 | $43,895,527,350 | 2 / 9 |
| 2026-10-26 | $3.39 | $43,895,527,350 | 2 / 9 |
| 2026-10-27 | $3.39 | $43,895,527,350 | 2 / 9 |
| 2026-10-28 | $3.39 | $43,880,451,817 | 2 / 9 |
| 2026-10-29 | $3.39 | $43,905,956,806 | 2 / 9 |
| 2026-10-30 | $3.39 | $43,905,956,806 | 2 / 9 |
| 2026-10-31 | $3.39 | $43,905,956,806 | 2 / 9 |
| 2026-11-01 | $3.39 | $43,905,956,806 | 2 / 9 |
| 2026-11-02 | $3.39 | $43,905,956,806 | 2 / 9 |
| 2026-11-03 | $3.38 | $33,284,223,279 | 2 / 9 |
| 2026-11-04 | $3.38 | $33,284,223,279 | 2 / 9 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
0 raises · 1 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.